HCA

HCA Healthcare, Inc. - 10-Q Summary (Period Ended June 30, 2006)

Business Context and Reporting Period

This is a Quarterly Report on Form 10-Q for HCA Inc., a holding company owning and operating hospitals and related health care entities. The report covers the quarterly and six-month periods ended June 30, 2006. As of June 30, 2006, HCA affiliates owned and operated 176 hospitals and 92 freestanding surgery centers across 21 U.S. states, England, and Switzerland. The company operates in three geographic groups: Eastern, Central, and Western, plus a Corporate and other group.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Revenues increased 4.8% in Q2 2006 and 4.3% for the six months ended June 30, 2006, driven by a 6.5% increase in revenue per equivalent admission, partially offset by a 1.6% decline in equivalent admissions.
• Profitability Decline: Net income decreased 27.1% in Q2 and 17.7% for the six months compared to the prior year. This decline is attributed to higher interest expense, increased provision for doubtful accounts, and the adoption of new accounting standards for share-based compensation.
• Uninsured Discounts: The company recorded $258 million in discounts to uninsured patients in Q2 2006 (vs. $184 million in Q2 2005), significantly impacting the provision for doubtful accounts, which rose to 10.6% of revenues (14.1% adjusted for discounts).
• Professional Liability: A favorable $85 million reduction in estimated professional liability reserves was recognized in Q2 2006 (vs. $36 million in Q2 2005), attributed to tort reforms and improved risk management.
• Interest Expense: Interest expense increased to $196 million in Q2 2006 from $165 million in Q2 2005 due to higher average debt balances and interest rates.

Guidance, Outlook, and Risks

• Merger Agreement: On July 24, 2006, HCA entered into a merger agreement to be acquired by a consortium of private equity firms (Bain Capital, KKR, Merrill Lynch) for $51.00 per share in cash. The transaction is expected to close in Q4 2006, subject to shareholder approval and regulatory conditions.
• Capital Allocation: The company completed a $2.5 billion share repurchase program in the first six months of 2006. Capital expenditures are expected to approximate $1.9 billion for the full year 2006.
• Legal and Regulatory Risks:
  • IRS Disputes: The IRS is seeking an additional $592 million in taxes, interest, and penalties regarding returns from 1990-2002. Management believes provisions are adequate.
  • Government Investigations: Ongoing investigations by the SEC and the U.S. Attorney for the Southern District of New York regarding trading in HCA securities.
  • Merger Litigation: Multiple class-action lawsuits have been filed challenging the merger process and consideration.
• Accounting Changes: Adoption of SFAS 123(R) for share-based compensation resulted in an additional $10 million expense in Q2 2006.

Investor Verification Checklist

• Merger Completion: Verify the status of shareholder approval and regulatory clearance for the $51.00/share buyout by the private equity consortium.
• Uninsured Patient Trends: Monitor the growth in uninsured admissions (up 10.5% same-facility in Q2) and the associated impact on the provision for doubtful accounts.
• IRS Resolution: Track the outcome of the ongoing tax disputes involving potential liabilities of $592 million.
• Debt Structure: Assess the impact of the proposed merger financing, which may involve significant new debt issuance to fund the transaction.
• Legal Proceedings: Review updates on the SEC investigation and the various shareholder derivative and class-action lawsuits related to the merger and prior disclosures.